Rectal spacer use and overall long-term healthcare costs: payer perspective
Patients with RS use undergoing PCa RT had significantly lower long-term overall healthcare costs despite incurring higher initial costs prior to and during RT, suggesting that upfront investment in RS may be offset by long-term savings for insurers.
Authors
- Daniel A. Hamstra (ORCID: https://orcid.org/0000-0001-6291-3444)
- Samir Bhattacharyya (ORCID: https://orcid.org/0009-0008-2534-0702)
- Michael R. Folkert (ORCID: https://orcid.org/0000-0003-3062-9793)
- James B. Yu (ORCID: https://orcid.org/0000-0002-3119-3226)
- Emmanuel Ezekekwu (ORCID: https://orcid.org/0000-0002-3080-9463)
- Ryoko Sato
Institutions
- Dartmouth–Hitchcock Medical Center (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- Boston Scientific (United States) (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.3389/fonc.2025.1654925
- Primary Topic
- Diverticular Disease and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation